Asuragen Forms Collaborations to Develop FNA Version of Pancreatic Cancer miRNA Test

The test is expected to be available through Asuragen's clinical laboratory improvement amendments-certified lab in the second half of this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories